Alcohol Effects on Driving-related Skills of Young Drivers

Sponsor
Centre for Addiction and Mental Health (Other)
Overall Status
Completed
CT.gov ID
NCT02710578
Collaborator
Ontario Ministry of Transportation (Other)
30
1
2
16.6
1.8

Study Details

Study Description

Brief Summary

Given the known driving behavior of Driving Under the Influence of Alcohol and some of its parallel to driving under the influence of cannabis, this supplemental study aims to validate the sensitivity of the primary and secondary outcome measures employed in a cannabis and driving study currently in progress.

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

This study will examine the effects of an intoxicating dose of alcohol on driving-related skills among young drivers using driving simulator technology.

This study is a double-blind, placebo-controlled mixed design study, including randomized between-subjects comparison of the effects of alcohol intoxication and both between- and within-subjects examination of acute and residual effects at approximately 24 and 48 hours following one-time alcohol administration.

Initial contact with potential participants will be made by telephone, where study personnel will conduct a telephone screen for eligibility. Those telephone screened as eligible will attend CAMH for an eligibility assessment. Enrolled participants will complete four sessions on consecutive days: a practice day, an alcohol administration day, and a 24-hour and 48-hour post-alcohol session.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Basic Science
Official Title:
Acute and Residual Effects of Alcohol on Young Drivers' Performance of Driving Related Skills
Study Start Date :
Mar 1, 2016
Actual Primary Completion Date :
Jul 18, 2017
Actual Study Completion Date :
Jul 18, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Alcohol

Alcohol

Drug: Alcohol
A single oral administration of an alcoholic beverage mixed in a 1:3 ratio of alcohol (Vodka) to tonic water to obtain a target BAC of 0.08mg%
Other Names:
  • Smirnoff Vodka
  • Placebo Comparator: Placebo

    Tonic water

    Drug: Placebo
    A single oral administration of a beverage containing tonic water of the same volume as the alcoholic beverage.
    Other Names:
  • Tonic water
  • Outcome Measures

    Primary Outcome Measures

    1. Psychomotor impairment (driving) [Approximate Time Frame: 30 minutes before, 30 minutes after, 24 and 48 hours after drinking]

      The driving simulator will objectively measure changes in driving behaviour after drinking alcohol.

    Secondary Outcome Measures

    1. Subjective alcohol effects [Approximate Time Frame: 30 minutes before drinking, 5, 15, 30 minutes and 1, 2, 3, 24 and 48 hours post-drinking]

      Visual analogue scale measures how participants feel before and after drinking alcohol. administration.

    2. Cognitive testing [Approximate Time Frame: 30 minutes before drinking, and 1, 24 and 48 hours post-drinking]

      Changes in Continuous Performance Test performance.

    3. Breath alcohol content (BAC) [Approximate Time Frame: 30 minutes before drinking, 5, 15, 30, minutes and 1, 2, 3, 24, and 48 hours post-drinking]

      Changes in BAC after drinking

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    19 Years to 25 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Males and females aged 19 to 25.

    • Reported consumption of at least 1 heavy drinking episode (according to NIAAA criteria of 5 drinks for males and 4 for females within an occasion) in the 6 months prior to eligibility assessment.

    • Held a valid class G or G2 Ontario driver's license (or equivalent from another jurisdiction) for at least 12 months.

    • Willing to abstain from alcohol use for the duration of the study, and for 48 hours prior to Session 2.

    • Provides written and informed consent.

    Exclusion Criteria:
    • Taking medications or have any medical condition for which alcohol is contraindicated

    • Is a regular user of medications that affect brain function (i.e., antidepressants, benzodiazepines, stimulants).

    • Diagnosis of severe medical or psychiatric conditions.

    • Meets criteria for current or lifetime Substance Use Disorders (DSM-IV) with the exception of nicotine.

    • Meets criteria for Alcohol Dependence (DSM-IV)

    • Is pregnant, is trying to become pregnant, or is currently breastfeeding.

    • Severe allergic reaction to citrus.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Centre for Addiction and Mental Health Toronto Ontario Canada M5S 2S1

    Sponsors and Collaborators

    • Centre for Addiction and Mental Health
    • Ontario Ministry of Transportation

    Investigators

    • Principal Investigator: Robert Mann, PhD, Centre for Addiction and Mental Health
    • Principal Investigator: Bernard Le Foll, MD, PhD, Centre for Addiction and Mental Health
    • Principal Investigator: Bruna Brands, PhD, Centre for Addiction and Mental Health

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Robert Mann, Senior Scientist, Centre for Addiction and Mental Health
    ClinicalTrials.gov Identifier:
    NCT02710578
    Other Study ID Numbers:
    • 114/2014
    First Posted:
    Mar 17, 2016
    Last Update Posted:
    Jan 29, 2019
    Last Verified:
    Jan 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Robert Mann, Senior Scientist, Centre for Addiction and Mental Health
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 29, 2019